[1-((E)-1-Cyclooct-1-enyl)methyl-piperidin-4-yl]-carbamic acid tert-butyl ester, 95.0%, 500mg

2-(5-Bromofuran-2-yl)-1,3-dioxolane, 97%, 5g

1-(Bromomethyl)-3-phenoxybenzene>98.0%(GC)1g

6,7-Dimethoxy-4-(trifluoromethyl)quinolin-2(1H)-one, 98.0%, 5g

Butanoic acid, 2,4-bis[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-, 98%, 10g

3'-cyano-3-(4-fluorophenyl)propiophenone, 97.0%, 1g

3-Fluoro-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-ol, 95.0%, 100mg

2-Bromo-6-(difluoromethyl)pyridine, 95.0%, 25g

2-(3-(3-Methoxyphenyl)allylidene)malonic acid, 95.0%, 5g

Objectif Plan Fluarex PLFi 20x/0.50 IOS corrigé à l'infini. Distance de travail 1,5 mm

2,3-NAPHTHALENEDICARBOXALDEHYDE, 95.0%, 1g

3-(1H-1,2,4-Triazol-1-yl)benzoic acid, 95.0%, 5g

1-(2-chloro-4-nitrophenyl)-3-(ethoxycarbonyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g